RC
Rob Carlson
OtherModerateManaging Director at Bioeconomy Capital
Seattle, United StatesFounded 2012
8
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Rob Carlson.
Investment Thesis & Strategy
Bioeconomy Capital, led by Rob Carlson, invests in various stages of biotech companies, focusing on those within the bioeconomy. They seek to support companies that are developing innovative solutions within the biotech space.
Investment Activity
Deals per year over the last 10 years
1
20100
20110
20120
20133
20140
20151
20161
20170
20182
2019Portfolio Companies
Selected investments from their portfolio of 8 companies
P
Parse Biosciences
Biotech · Series A, 2019
B
Bellwether Bio
Biotech · Seed, 2019
L
Lumen Bioscience
Biotech · Series A, 2017
R
RoosterBio
Biotech · Series A, 2016
R
Riffyn
Biotech · Series A, 2014
Z
Zymergen
Biotech · Series B, 2014
S
Synthace
Biotech · Series B, 2014
A
Arzeda
Biotech · Series B, 2010
Frequently Asked Questions
Rob Carlson focuses on Seed stage investments.